This activity is expired and is no longer available for CME credit.


Comparison of Available Oral MS Therapies

Author(s)/Faculty: Bruce A. Cohen, MD
Release Date: 8/16/2016Expiration Date: 8/15/2018
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Oral therapies are revolutionizing multiple sclerosis (MS) treatment as they offer enhanced dosing along with higher rates of patient compliance. There are currently three approved oral therapies for MS (teriflunomide, fingolimod, and dimethyl fumarate). This CME activity will compare the three available oral therapies for MS.